Thomas Bures
Director of Finance/CFO bei PIERIS PHARMACEUTICALS, INC.
Vermögen: 3 527 $ am 31.03.2024
Profil
Thomas Bures is currently the Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. He previously worked as the Vice President & Assistant Controller at PAREXEL International Corp.
and as the Vice President & Controller at Genocea Biosciences, Inc. He obtained his undergraduate degree from the College of the Holy Cross (Massachusetts).
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.04.2023 | 19 273 ( 0,02% ) | 3 527 $ | 31.03.2024 |
Aktive Positionen von Thomas Bures
Unternehmen | Position | Beginn |
---|---|---|
PIERIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 13.09.2019 |
Ehemalige bekannte Positionen von Thomas Bures
Unternehmen | Position | Ende |
---|---|---|
GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01.12.2017 |
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Thomas Bures
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENOCEA BIOSCIENCES, INC. | Health Technology |
PIERIS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
PAREXEL International Corp.
PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |